checkAd

     628  0 Kommentare Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the Joint Terms of Merger - Seite 2

      BEBIG EZAG
    Enterprise Value (EV) EUR 34,887k EUR 387,015k
    EBITDA 2017 EUR 4,714k EUR 29.744k
    EV/EBITDA ratio 7.4x 13.01x

    For an explanation regarding the observed differences, see section 7.2.4 and 7.5 of the special report of the board of directors of BEBIG.

    Shareholder meeting

    The proposed merger will be submitted for approval to the Extraordinary General Shareholders Meeting of BEBIG, which is scheduled to take place on 21 December 2018 at 10:00 am. All formalities related to the convening of this meeting will be accomplished in due course. The proposed merger will also be submitted for approval to the Extraordinary General Shareholders Meeting of EZAG which is scheduled to take place on 20 December 2018 at 10:00 am.

    The merger is expected to be effective before January 31, on the date on which the commercial register of EZAG, i.e. the Handelsregister Berlin-Charlottenburg, will register the Merger into the commercial register of EZAG further to the approval of the shareholders (the Legal Effective Date).

    Fractions of shares

    The fractions of EZAG Exchange Shares resulting from the Exchange Ratio will initially be allocated to the shareholders in a separate ISIN for partial rights. The custodian banks of the BEBIG Shareholders are requested to transfer the full EZAG Exchange Shares and the combined partial rights to full EZAG Exchange Shares booked with the respective shareholders into the common ISIN of the EZAG Shares. After a conversion period of at least 10 days, the remaining partial rights will be subject to a compulsory merger into full EZAG Exchange Shares by Clearstream Banking AG via the Trustee's account. The Trustee will then sell all full EZAG Exchange Shares on the stock exchange for the account of the shareholders concerned. After this realization, the Trustee will distribute the cash proceeds to the shareholders in proportion to the fractions allocated to them, with the involvement of the custodian banks or depositaries.

    Contact:
    Eckert & Ziegler BEBIG SA
    Investor Relations
    Tel. +32 64 520 808
    E-Mail: ir@bebig.com 




    This announcement is distributed by West Corporation on behalf of West Corporation clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Eckert & Ziegler BEBIG via Globenewswire

    Seite 2 von 2



    GlobeNewswire
    0 Follower
    Autor folgen
    Verfasst von GlobeNewswire
    Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the Joint Terms of Merger - Seite 2 Press release  REGULATED INFORMATION Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the common draft terms of the cross-border merger (Joint Terms of …